The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIq-ai Ltd Regulatory News (IQAI)

Share Price Information for Iq-ai Ltd (IQAI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 1.60
Ask: 1.80
Change: 0.05 (3.03%)
Spread: 0.20 (12.50%)
Open: 1.65
High: 1.90
Low: 1.65
Prev. Close: 1.65
IQAI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director Dealings and Conversion of CLNs

15 Jan 2024 07:01

RNS Number : 6148Z
IQ-AI Limited
15 January 2024
 

IQ-AI Ltd

("IQ-AI" or the "Company")

 

Director Dealings and Conversion of Convertible Loan Notes

IQ-AI Ltd has received convertible loan note conversion notices from Trevor Brown, the CEO of IQ-AI, and Micheal Schmainda, a director of IQ-AI. Trevor Brown is converting a total of £60,000 convertible loan notes and associated interest, issued in May 2019, at a price of 1.5 pence, into 5,111,233 Ordinary Shares. Michael Schmainda is converting a total of £18,500 convertible loan notes and associated interest, issued in March 2019, at a price of 2 pence, into 1,193,681 Ordinary Shares which will be issued to his wife, Kathleen Schmainda (together the "CLN Shares").

 

Following the above transactions, Trevor Brown will hold 45,761,083 Ordinary Shares, representing approximately 23.23 per cent. of the Company's enlarged issued share capital. In addition, Kathleen Schmainda, who is also a consultant and existing shareholder in IQ-AI, will hold 10,302,081 Ordinary Shares, representing approximately 5.23 per cent. of the Company's enlarged issued share capital.

 

IQ-AI has no outstanding convertible loan notes following the above conversions. 

 

An application will be made for 6,304,914 CLN Shares to be admitted to the Official List of the UK Listing Authority by way of a Standard Listing ("Admission") and it is expected that Admission will become effective and that dealing in the CLN Shares will commence on or around 8am on 19 January 2024. The CLN Shares will rank pari passu with the existing ordinary shares of the Company.

 

Following Admission, the Company will have 196,976,456 ordinary shares of 0.01p each in issue, none of which are held in treasury. Therefore, the total number of voting rights in the Company will be 196,976,456.

 

The above figure of 196,976,456 may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

--ENDS-

 

The Directors of the Company accept responsibility for the contents of this announcement.

 

For further information, please contact:

 

IQ-AI Ltd

Trevor Brown/Vinod Kaushal/Brett Skelly/Michael Schmainda

Tel: 020 7469 0930

Peterhouse Capital Limited (Financial Adviser and Broker)

Lucy Williams/Heena Karani

Tel: 020 7220 9797

 

 

About Imaging Biometrics® LLC IB is a wholly owned subsidiary of IQ-AI Limited, (LON: IQAI), and focuses on delivering quantitative imaging platforms and therapeutics that transform how clinicians diagnose and treat patients more efficiently and effectively. For more information about Imaging Biometrics, visit the company's website atwww.imagingbiometrics.comFollow IB on Twitter, @IQAI_IB.

 

 PDMR DEALINGS

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Trevor Brown

2

Reason for the notification

a)

Position/status

CEO

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IQ-AI Ltd

b)

LEI

213800SPW48XRJS2QH57

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of £0.01 each

 

 

 

ISIN: JE00BD4H0R42

b)

Nature of the transaction

Conversion of convertible loan notes

c)

Price(s) and volume(s)

Exercise price of each convertible loan note :1.5p

Volume: 5,111,233

d)

Aggregated information

- Aggregated volume

- Price

 

e)

Date of the transaction

15 January 2024

f)

Place of the transaction

Main Market

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Michael Schmainda

2

Reason for the notification

a)

Position/status

Director

b)

Initial notification /Amendment

Initial

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

IQ-AI Ltd

b)

LEI

213800SPW48XRJS2QH57

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary Shares of £0.01 each

 

 

 

ISIN: JE00BD4H0R42

b)

Nature of the transaction

Conversion of convertible loan notes

c)

Price(s) and volume(s)

Exercise price of each convertible loan note :2p

Volume: 1,193,681

d)

Aggregated information

- Aggregated volume

- Price

 

e)

Date of the transaction

15 January 2024

f)

Place of the transaction

Main Market

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFFFSLLIISLIS
Date   Source Headline
3rd Jul 20086:23 pmRNSTrading Statement
4th Jun 20085:35 pmRNSHolding(s) in Company
2nd Jun 20089:59 amRNSCEO Appointment
29th May 20083:30 pmRNSTrading Statement
8th May 20085:01 pmRNSAnnual Information Update
8th May 20084:27 pmRNSBlocklisting Interim Review
8th May 20084:26 pmRNSAnnual Report and Accounts
23rd Apr 200810:19 amRNSAGM Statement
14th Mar 20087:01 amRNSFinal Results
29th Feb 20087:01 amRNSNotice of Final Results
17th Jan 20081:39 pmRNSTrading Statement
13th Nov 20075:59 pmRNSHolding(s) in Company
23rd Oct 20077:02 amRNSTrading Update
27th Sep 200711:18 amRNSTotal Voting Rights
26th Sep 200711:00 amRNSBlocklisting Interim Review
6th Sep 20073:27 pmRNSDirectorate Change
27th Jul 20077:01 amRNSInterim Results
9th Jul 20077:00 amRNSNotice of Interim Results
6th Jul 200710:50 amRNSHolding(s) in Company
1st Jun 20078:00 amRNSHolding(s) in Company
8th May 20072:29 pmRNSDirector/PDMR Shareholding
25th Apr 200710:10 amRNSHolding(s) in Company
17th Apr 200710:44 amRNSAGM Statement & Board Changes
27th Mar 20072:40 pmRNSBlocklisting Interim Review
20th Mar 20079:01 amRNSHolding(s) in Company
16th Mar 20077:01 amRNSFinal Results
26th Feb 20077:00 amRNSNotice of Results
22nd Jan 20077:02 amRNSTrading Statement
19th Jan 20072:45 pmRNSHolding(s) in Company
15th Jan 20071:41 pmRNSHolding(s) in Company
13th Dec 200612:19 pmRNSTotal Voting Rights
29th Nov 20069:01 amRNSShareholder & Board Change
18th Oct 20062:16 pmRNSHolding(s) in Company
16th Oct 200611:49 amRNSHolding(s) in Company
26th Sep 200610:31 amRNSBlocklisting Interim Review
21st Sep 200610:12 amRNSHolding(s) in Company
18th Sep 20067:01 amRNSAcquisition
10th Aug 200610:19 amRNSHolding(s) in Company
8th Aug 20067:01 amRNSTransaction in Own Shares
28th Jul 20067:01 amRNSInterim Results
18th Jul 20067:00 amRNSNotice of Interim Results
27th Jun 20064:52 pmRNSChange of Auditors
3rd May 20065:09 pmRNSDirectorate Change
28th Apr 20067:01 amRNSHolding(s) in Company
13th Apr 200610:15 amRNSAGM Statement
6th Apr 200610:26 amRNSDirector/PDMR Shareholding
24th Mar 20064:17 pmRNSAdditional Listing - Replace
23rd Mar 20063:28 pmRNSAdditional Listing
16th Mar 20063:18 pmRNSDirector/PDMR Shareholding
14th Mar 20063:43 pmRNSAnnual Information Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.